Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Kenneth R. Carson"'
Autor:
Martin W. Schoen, Kenneth R. Carson, Suhong Luo, Brian F. Gage, Ang Li, Amber Afzal, Kristen M. Sanfilippo
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 7, Pp 1203-1210 (2020)
Abstract Background In multiple myeloma, venous thromboembolism (VTE) is common, and treatments for myeloma, such as lenalidomide, increase the risk of thrombosis while improving survival. The association between VTE and survival is not well known. O
Externí odkaz:
https://doaj.org/article/35c5a7b44b4f44ac9a45101124ca3a28
Autor:
Kristen M. Sanfilippo, Kenneth R. Carson, Tzu‐Fei Wang, Suhong Luo, Natasha Edwin, Nicole Kuderer, Jesse M. Keller, Brian F. Gage
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)
Abstract Background Guidelines recommend thromboprophylaxis for patients with multiple myeloma (MM) at high risk for venous thromboembolism (VTE). However, the optimal risk prediction model for VTE in MM remains unclear. Khorana et al developed a VTE
Externí odkaz:
https://doaj.org/article/113ae2b1ee5345e4ad565ab4976b3933
Autor:
Jared M. Andrews, Jennifer A. Schmidt, Kenneth R. Carson, Amy C. Musiek, Neha Mehta-Shah, Jacqueline E. Payton
Publikováno v:
EBioMedicine, Vol 46, Iss , Pp 170-183 (2019)
Background: Treatment for Cutaneous T Cell Lymphoma (CTCL) is generally not curative. Therefore, selecting therapy that is effective and tolerable is critical to clinical decision-making. Histone deacetylase inhibitors (HDACi), epigenetic modifier dr
Externí odkaz:
https://doaj.org/article/aedb9d7ddd2a48bebd9a1e1008a9ce36
Autor:
Charles L. Bennett, Shamia Hoque, Nancy Olivieri, Matthew A. Taylor, David Aboulafia, Courtney Lubaczewski, Andrew C. Bennett, Jay Vemula, Benjamin Schooley, Bartlett J. Witherspoon, Ashley C Godwin, Paul S. Ray, Paul R. Yarnold, Henry C. Ausdenmoore, Marc Fishman, Georgne Herring, Anne Ventrone, Juan Aldaco, William J. Hrushesky, John Restaino, Henrik S. Thomsen, Robert Marx, Cesar Migliorati, Salvatore Ruggiero, Chadi Nabhan, Kenneth R. Carson, June M. McKoy, Y. Tony Yang, Martin W. Schoen, Kevin Knopf, Linda Martin, Oliver Sartor, Steven Rosen, William K. Smith
Publikováno v:
EClinicalMedicine, Vol 31, Iss , Pp 100693- (2021)
Background: Adverse drug/device reactions (ADRs) can result in severe patient harm. We define very serious ADRs as being associated with severe toxicity, as measured on the Common Toxicity Criteria Adverse Events (CTCAE)) scale, following use of drug
Externí odkaz:
https://doaj.org/article/7660e72814e34fe8aaa2b0680f081e61
Autor:
Norihiko Oharu, Patrick Schnell, Keith D. Wilner, Jack Mardekian, Michelle Yu-Kite, Diane D. Wang, Jillian Motyl Rockland, Dongrui R. Lu, Todd VanArsdale, Jennifer M. Tursi, Albert L. Kraus, Cynthia Huang Bartlett, Matthew J. Cotter, Kenneth R. Carson, Jaclyn Decembrino, Sindy T. Kim, Anala Gossai, Tamara Snow
Publikováno v:
Clinical Pharmacology & Therapeutics. 111:302-309
This report examined the benefits and risks of palbociclib plus endocrine therapy (ET) in men with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). Palbociclib was evaluated usi
Publikováno v:
Cancer treatment and research. 184
More than half of all serious adverse drug reactions are identified seven years after FDA approval. One recent and unusual example involves a syndrome initially termed nephrogenic dermatopathic fibrosis, and then called nephrogenic systemic fibrosis
Publikováno v:
Cancer treatment and research. 184
Progressive multifocal leukoencephalopathy (PML) is a John-Cunningham virus-related central nervous system that is rarely observed in persons treated with the anti-CD20 monoclonal antibody, rituximab.
Autor:
Martin W. Schoen, Kenneth R. Carson, Seth A. Eisen, Charles L. Bennett, Suhong Luo, Melissa A. Reimers, Eric M. Knoche, Alison L. Whitmer, Yan Yan, Bettina F. Drake, Kristen M. Sanfilippo
Publikováno v:
Prostate Cancer and Prostatic Diseases.
Background Comorbid diseases influence patient outcomes, yet little is known about how comorbidities interact with treatments for metastatic castrate-resistant prostate cancer (mCRPC). No head-to-head trials have compared the efficacy of abiraterone
Autor:
Carlos Chiattone, Monica Civallero, Thais Fischer, Eliana Miranda, Martina Manni, Natalia P. C. Zing, Stefano A. Pileri, Silvia Montoto, Steven M. Horwitz, Maria Elena Cabrera, Carmino A. De Souza, Arnon Nagler, Stefano Luminari, Andrés J. M. Ferreri, Kenneth R. Carson, Alessandro Re, Luigi Rigacci, Luca Nassi, Yana Stepanishyna, Massimo Federico, Giorgio Inghirami
Publikováno v:
Hematological oncologyREFERENCES.
The T-cell Lymphoma Project is an international registry prospective study that enrolled patients with newly diagnosed peripheral T-cell and NK-cell lymphomas (PTCL). The main objective was to define the clinical features and outcomes, establishing a
Autor:
Siraj M. Ali, Junya Fujimoto, Elad Sharon, Garrett M. Frampton, Kathleen Maignan, Aracelis Z. Torres, Gerald Li, Ignacio I. Wistuba, Vinodh N. Rajapakse, Jeremy Snider, Eva Szabo, Camille Tlemsani, Nobuyuki Takahashi, Javed Khan, Samantha Nichols, Anish Thomas, Jun Wei, Se Hyun Kim, Kenneth R. Carson, Idrees Mian, Udayan Guha, Cesar A Moran, Lorinc Pongor
Publikováno v:
Chest. 158:1723-1733
Background Small cell lung cancer (SCLC) has the strongest association with smoking among lung cancers. The characteristics of never smokers with SCLC is not known. Research Question Are the clinical characteristics, prognostic factors, survival, gen